138306-24-8 Usage
Description
(S)-METHYL 4-HYDROXY-3-METHYLBUTYRATE, also known as HMB, is a naturally occurring compound derived from the metabolism of the amino acid leucine. It is characterized by its potential to support muscle growth, enhance athletic performance, and facilitate recovery from strenuous exercise. HMB is recognized for its ability to reduce muscle damage, increase muscle strength, and promote fat loss, while also exhibiting anti-catabolic effects that may help prevent muscle tissue breakdown during periods of intense physical activity or calorie restriction. It has been deemed safe and well-tolerated by most individuals, with minimal side effects reported.
Uses
Used in Athletic Performance Enhancement:
(S)-METHYL 4-HYDROXY-3-METHYLBUTYRATE is used as a dietary supplement for athletes and bodybuilders to support muscle growth and improve athletic performance. It aids in recovery after intense exercise by reducing muscle damage and promoting the repair of muscle tissue.
Used in Muscle Recovery and Strengthening:
In the fitness industry, (S)-METHYL 4-HYDROXY-3-METHYLBUTYRATE is used as a recovery aid to help reduce muscle damage and increase muscle strength. Its anti-catabolic effects may prevent the breakdown of muscle tissue during periods of intense physical activity or calorie restriction, thus contributing to a more efficient muscle recovery process.
Used in Fat Loss and Weight Management:
(S)-METHYL 4-HYDROXY-3-METHYLBUTYRATE is utilized as a component in fat loss and weight management programs, as it has been shown to promote fat loss while supporting muscle growth and strength. This dual action makes it a valuable addition to the regimens of those seeking to improve their body composition.
Used in Sports Nutrition:
Within the sports nutrition sector, (S)-METHYL 4-HYDROXY-3-METHYLBUTYRATE is employed as an ingredient in various supplements and products designed to enhance muscle growth, strength, and recovery. Its inclusion in these products aims to provide athletes and fitness enthusiasts with the necessary support to optimize their training and performance outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 138306-24-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,3,0 and 6 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 138306-24:
(8*1)+(7*3)+(6*8)+(5*3)+(4*0)+(3*6)+(2*2)+(1*4)=118
118 % 10 = 8
So 138306-24-8 is a valid CAS Registry Number.
138306-24-8Relevant articles and documents
Metathesis for catalyst design: Metacatalysis
Khumsubdee, Sakunchai,Burgess, Kevin
, p. 1326 - 1335 (2014/02/14)
Prior studies have shown an effective way to produce diverse ligand sets for catalyst discovery is by using mixtures of monodentate forms to generate catalysts in situ. Research described here was performed to illustrate that alkene-functionalized monodentate ligands could be used in this way and in another that increases the diversity of the ligand library in an interesting way. Specifically, we hypothesized that as well as being used as monomers, these alkenes could be cross metathesized in situ immediately before the catalysis step. This combination of metathesis to form ligands in situ, then catalysis is referred to here as metacatalysis. In the event, a library of quinidine and quinine alkaloid-derived phosphites were tested as mixtures of monomers and dimers formed via metathesis in situ. The data obtained illustrated that metacatalysis can be used to identify ligands that positively and negatively modulate enantioselectivities in iridium-mediated hydrogenations of α,β-unsaturated carboxylic acid derivatives, relative to the mixtures of the monomeric forms used.
A comparison between oxazoline-imidazolinylidene, -imidazolylidine, -benzimidazolylidene hydrogenation catalysts
Khumsubdee, Sakunchai,Fan, Yubo,Burgess, Kevin
, p. 9969 - 9974 (2013/10/22)
Imidazolinylidene, imidazolylidine, benzimidazolylidene complexes 1a-c were prepared and tested in asymmetric hydrogenations of a series of largely unfunctionalized alkenes. Similarities and differences in the catalytic performance of these complexes were rationalized in terms of the predicted mechanisms of these reactions, and their relative tendencies to generate protons under the hydrogenation conditions.
Total syntheses of amphidinolide H and G
Fuerstner, Alois,Bouchez, Laure C.,Funel, Jacques-Alexis,Liepins, Vilnis,Poree, Francois-Hugues,Gilmour, Ryan,Beaufils, Florent,Laurich, Daniel,Tamiya, Minoru
, p. 9265 - 9270 (2008/12/22)
(Chemical Equation Presented) Eureka! The first conquest of the exceptionally potent cytotoxic agent amphidinolide H, which exhibits activity in the picomolar range against human epidermoid cancer cells, was long overdue. The successful route critically h
